Please login to the form below

Not currently logged in
Email:
Password:

drug discovery

This page shows the latest drug discovery news and features for those working in and with pharma, biotech and healthcare.

AZ makes gene therapy move with 4DMT alliance

AZ makes gene therapy move with 4DMT alliance

It’s been applying CRISPR to its drug discovery programmes for a few years, and earlier this year presented early data from animal studies showing that a CRISPR-based drug could

Latest news

More from news
Approximately 7 fully matching, plus 413 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    Operating mostly under the radar this service has yet to market itself widely but the potential to identify cost-effective and clinically successful drug regimes is enormous. ... The fact that innovation outside the core drug discovery business is

  • 30 Women Leaders in UK Healthcare (part 2)

    11. Jackie Hunter, CEO, BenevolentBio. Jackie Hunter is a hugely experienced drug discovery scientist who is now championing the use of AI to transform pharma R&D. ... In the meantime, she is challenging not just the accepted ways of conducting drug

  • 30 Women Leaders in UK Healthcare

    Dr Marshall is a world-leading expert in G-Protein-Coupled-Receptor (GPCR) biology and drug discovery. ... Noor Shaker believes her young start-up company GTN can revolutionise drug discovery through the application of artificial intelligence, and

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    This includes tackling one of the world’s biggest health problems today – the growing threat of drug resistant ‘superbugs’. ... tools for drug discovery and as direct therapies for currently untreatable conditions.

  • Health on instalment Health on instalment

    Importantly, genetic remedies skip the painstaking middle step of drug discovery. ... For example, the ophthalmic drug Luxturna, approved last year, costs $850, 000 per dose.

More from intelligence
Approximately 0 fully matching, plus 51 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28 years’experience in clinical development and drug discovery. ... Concept Life Sciences appoints John Vu as

  • Concept Life Sciences adds to its team Concept Life Sciences adds to its team

    Integrated drug discovery, development and analytical services company Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley Park unit based in Cheshire, UK. ... She said: “I am looking forward to applying my own drug

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan to its board of directors, a move that will see ... Dr Kenny is currently chief business officer of Heptares

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Also joining the company is Dr Tim Calvert (pictured left), who becomes its vice president of business development, integrated discovery services, Europe. ... Dr Calvert has experience in the delivery of integrated drug discovery and development solutions

More from appointments
Approximately 0 fully matching, plus 70 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics